This edition includes research on the mental health outcomes of cancer patients, cardiovascular disease risk for people with latent TB, and a cost analysis of two treatments for prescription-type opioid use disorder.
Read More
CHÉOS Scientists are leading five of the funded projects and supporting a further five as co-investigators
Read More
CHÉOS Scientists are leading nine of the projects funded in this round, plus a further seven projects are supported by CHÉOS Scientists as co-investigators
Read More
Results from an innovative CHÉOS-led clinical trial show the sedative is effective, and could be safer for patients and staff
Read More
CHÉOS Scientists are leading eight of the projects funded in this round, plus a further fourteen projects are supported by CHÉOS Scientists as co-investigators
Read More
CHÉOS Scientists are leading three of the projects funded through this round of the competition and a further seven projects are supported by CHÉOS Scientists as co-investigators
Read More
A clinical trial for a new COVID-19 treatment developed by Vancouver biotech company AbCellera is about to launch in B.C., thanks to the expertise of CHÉOS staff
Read More
This edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read More
The 34th edition summarizes some of the latest research from CHÉOS Scientists: gender imbalance in ICU admission, urinary tract infection after gynecologic surgery, and recover from work-related injuries.
Read More
Read about the Scientists and research that appeared in the media this summer.
Read More